FMO5 抗体 (AA 251-350) (Cy7)
Quick Overview for FMO5 抗体 (AA 251-350) (Cy7) (ABIN1708654)
抗原
See all FMO5 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 251-350
-
交叉反应
- 人, 小鼠, 大鼠
-
预测反应
- Dog,Cow,Pig
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human FMO5
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- FMO5 (Flavin Containing Monooxygenase 5 (FMO5))
-
别名
- FMO5
-
背景
-
Synonyms: Dimethylaniline monooxygenase [N-oxide-forming] 5, Dimethylaniline oxidase 5, Hepatic flavin-containing monooxygenase 5, FMO 5, FMO5
Background: In contrast with other forms of FMO it does not seem to be a drug-metabolizing enzyme.
-
基因ID
- 2330
-
UniProt
- P49326
抗原
-